NCT04711109 2025-04-02BRCA-PAlliance for Clinical Trials in OncologyPhase 3 Active not recruiting300 enrolled
NCT01419717 2019-09-24Open-Label Access Protocol of Denosumab for Subjects With Advanced CancerAmgenPhase 3 Completed129 enrolled 10 charts
NCT00896454 2018-10-17Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumAmgenPhase 2 Completed33 enrolled 22 charts
NCT00950911 2014-02-11Open Label Extension to SRE Studies in United Kingdom and Czech Republic OnlyAmgenPhase 3 Completed35 enrolled 8 charts
NCT00091832 2014-01-28Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast CancerAmgenPhase 2 Completed255 enrolled 34 charts